Literature DB >> 11222911

HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis.

G Ferlazzo1, C Semino, G Melioli.   

Abstract

It has been widely demonstrated that natural killer (NK) cells are able to discriminate between normal and abnormal cells on the basis of the interaction of their NKRs with the MHC molecules expressed on the target cells. Recent studies showed that also normal dendritic cells are susceptible to NK cell-mediated lysis. In this work, the potential relationships between the expression of different surface molecules on both immature and mature DC and susceptibility to lysis have been investigated. The reduced density of HLA class I on the surface of immature DC resulted in the only permissive signal to NK cell mediated killing. On the contrary, the remarkable increase in HLA class I molecules detected during DC maturation was strictly related to the resistance to NK cell. Contemporary, no clear evidences of a role for other surface molecules modulated during DC maturation (CD80, CD83, CD86 and CD40), were obtained.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222911     DOI: 10.1016/s0165-2478(00)00323-0

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  18 in total

Review 1.  The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.

Authors:  Morgan E Wallace; Mark J Smyth
Journal:  Springer Semin Immunopathol       Date:  2005-02-24

2.  Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15.

Authors:  Lazar Vujanovic; David E Szymkowski; Sean Alber; Simon C Watkins; Nikola L Vujanovic; Lisa H Butterfield
Journal:  Blood       Date:  2010-04-29       Impact factor: 22.113

Review 3.  Liaison between natural killer cells and dendritic cells in human gestation.

Authors:  Ester Leno-Durán; Raquel Muñoz-Fernández; Enrique García Olivares; Irene Tirado-González
Journal:  Cell Mol Immunol       Date:  2014-06-23       Impact factor: 11.530

4.  Comparative analysis of NK-cell receptor expression and function across primate species: Perspective on antiviral defenses.

Authors:  Roberto Biassoni; Elisabetta Ugolotti; Andrea De Maria
Journal:  Self Nonself       Date:  2010-03-06

Review 5.  Role of TNF superfamily ligands in innate immunity.

Authors:  Nikola L Vujanovic
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

6.  Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional alterations of dendritic cells: a novel mechanism for AIDS pathogenesis.

Authors:  Laura Fantuzzi; Cristina Purificato; Karim Donato; Filippo Belardelli; Sandra Gessani
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant.

Authors:  M Paula Longhi; Christine Trumpfheller; Juliana Idoyaga; Marina Caskey; Ines Matos; Courtney Kluger; Andres M Salazar; Marco Colonna; Ralph M Steinman
Journal:  J Exp Med       Date:  2009-06-29       Impact factor: 14.307

8.  Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus.

Authors:  D de J Cruz-González; D Gómez-Martin; E Layseca-Espinosa; L Baranda; C Abud-Mendoza; J Alcocer-Varela; R González-Amaro; A E Monsiváis-Urenda
Journal:  Clin Exp Immunol       Date:  2017-11-22       Impact factor: 4.330

Review 9.  Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics.

Authors:  Valeria Rizzello; Irene Bonaccorsi; Maria Luisa Dongarrà; Lisbeth Nielsen Fink; Guido Ferlazzo
Journal:  J Biomed Biotechnol       Date:  2011-05-03

10.  Topographical and biological evidence revealed FTY720-mediated anergy-polarization of mouse bone marrow-derived dendritic cells in vitro.

Authors:  Xiangfeng Zeng; Tong Wang; Cairong Zhu; Xiaobo Xing; Yanxia Ye; Xinqiang Lai; Bing Song; Yaoying Zeng
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.